Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2014

View Archived Issues

Genetic profiling of CTCs to determine drug response in SCLC

Rediscovery of a natural compound to combat multidrug resistance in bacteria

TAXIS Pharmaceuticals presents novel antibacterial agents targeting FtsZ

New potent and selective Wnt signaling inhibitor with in vivo activity

Coherus BioSciences' adalimumab biosimilar shows pharmacokinetic similarity to Humira

Canadian government donates experimental Ebola vaccine to the WHO

HUYA partners with Changzhou Center for Biotech Development to progress Chinese drug development

Eisai proton pump inhibitor licensed by Zeria in Japan

Achillion reports interim data from phase II trial of ACH-3102 and sofosbuvir in HCV infection

Novel HPLC system measures serum apoE-HDLc

GlaxoSmithKline discloses new PAF acetylhydrolase inhibitors

Novel antiviral agents patented by Roche

Merck & Co. presents novel BTK inhibitors

Naurex discloses novel NMDA receptor modulators

Ampio Pharmaceuticals reports data from multiple-injection study of Ampion

Photocure provides update on partnership for Lumacan

Provectus signs agreement with Sinopharm-CSIPI and Sinopharm A-THINK Pharmaceutical

Clinical study of TG-1101, TGR-1202 and ibrutinib for CLL

Biogen Idec discloses novel S1P5 receptor modulators

Pfizer submits NDA for palbociclib to the FDA

NIH awards grant to Sedia Biosciences for rapid HIV-1 incidence assay

Eisai seeks approval for lenvatinib in Europe and the U.S.

Amarantus gains rights to MANF for retinal diseases from University of Miami

Sanofi and PATH deliver first antimalarial produced using semisynthetic artemisinin

Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...